Series D funding round for Turnstone Biologics raising $80M in July 2021
Series D funding round for Turnstone Biologics raising $80M in July 2021
| Investor | Firm Type | Partner |
|---|
Point72LEAD | Venture Capital | — |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private Equity | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$132M
Top Valuation
-
Turnstone Biologics raised $80M in a Series D round.
The round was announced on 07/01/21.
The round was led by Santhosh Palani, PhD, CFA, Point72.